GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1433-2965
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
GRAND-4: the German retrospective analysis of long-term persistence in women with osteoporosis treated with bisphosphonates or denosumab ; day:12 ; month:5 ; year:2016 ; pages:1-12
Osteoporosis international ; (12.5.2016), 1-12
- Urheber
-
Hadji, P.
- Beteiligte Personen und Organisationen
-
Kybernētakēs, Iōannēs
Kann, P. H.
Niedhart, C.
Hofbauer, L. C.
Schwarz, H.
Kurth, A. A.
Thomasius, F.
Schulte, M.
Intorcia, M.
Psachoulia, E.
Schmid, T.
SpringerLink (Online service)
- DOI
-
10.1007/s00198-016-3623-6
- URN
-
urn:nbn:de:1111-2016051727172
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:04 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hadji, P.
- Kybernētakēs, Iōannēs
- Kann, P. H.
- Niedhart, C.
- Hofbauer, L. C.
- Schwarz, H.
- Kurth, A. A.
- Thomasius, F.
- Schulte, M.
- Intorcia, M.
- Psachoulia, E.
- Schmid, T.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Treatment of osteoporosis with denosumab in patients with decreased kidney function
A reappraisal of generic bisphosphonates in osteoporosis
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Treatment of osteoporosis with denosumab in patients with decreased kidney function
A reappraisal of generic bisphosphonates in osteoporosis
Denosumab compared to bisphosphonates to treat postmenopausal osteoporosis: a meta-analysis
Medication-taking behaviour in Bulgarian women with postmenopausal osteoporosis treated with denosumab or monthly oral bisphosphonates
Persistence with oral bisphosphonates and denosumab among older adults in primary care in Ireland
Influence on persistence and adherence with oral bisphosphonates on fracture rates in osteoporosis
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Correction: Efficacy and safety of teriparatide vs. bisphosphonates and denosumab vs. bisphosphonates in osteoporosis not previously treated with bisphosphonates: a systematic review and meta-analysis of randomized controlled trials
Compliance and persistence with oral bisphosphonates for the treatment of osteoporosis in female patients with rheumatoid arthritis
Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study
Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study
Treatment of osteoporosis with denosumab in patients with decreased kidney function